» Articles » PMID: 17062703

Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2006 Oct 26
PMID 17062703
Citations 234
Authors
Affiliations
Soon will be listed here.
Abstract

Certain solid tumors metastasize to bone and cause osteolysis and abnormal new bone formation. The respective phenotypes of dysregulated bone destruction and bone formation represent two ends of a spectrum, and most patients will have evidence of both. The mechanisms responsible for tumor growth in bone are complex and involve tumor stimulation of the osteoclast and the osteoblast as well as the response of the bone microenvironment. Furthermore, factors that increase bone resorption, independent of tumor, such as sex steroid deficiency, may contribute to this vicious cycle of tumor growth in bone. This article discusses mechanisms and therapeutic implications of osteolytic and osteoblastic bone metastases.

Citing Articles

The Tight Relationship Between the Tumoral Microenvironment and Radium-223.

Conte M, Tomaciello M, De Feo M, Frantellizzi V, Marampon F, De Cristofaro F Biomedicines. 2025; 13(2).

PMID: 40002869 PMC: 11853176. DOI: 10.3390/biomedicines13020456.


Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments.

Hamza F, Mohammad K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770433 PMC: 11679356. DOI: 10.3390/ph17121591.


Bone marrow magnetic resonance imaging (MRI): morphological and functional features from reconversion to infiltration.

Vilanova C, Martin-Noguerol T, Garcia-Figueiras R, Baleato-Gonzalez S, Vilanova J Quant Imaging Med Surg. 2024; 14(11):7969-7982.

PMID: 39544475 PMC: 11558494. DOI: 10.21037/qims-23-1678.


Effect of colony‑stimulating factor in the mechanism of bone metastasis development (Review).

Han Y, Wang Y, Lv T, Yang Q, Cheng D, Li J Oncol Rep. 2024; 52(6).

PMID: 39422059 PMC: 11544585. DOI: 10.3892/or.2024.8824.


SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer.

Tang C, Lai Y, Li L, Situ M, Li S, Cheng B iScience. 2024; 27(8):110427.

PMID: 39161960 PMC: 11332800. DOI: 10.1016/j.isci.2024.110427.